Positron emission tomography: theory and its application to the study of lung disease.

[1]  J. Frost Receptor localization and quantification with PET. , 1988, Radiology.

[2]  M. Mintun,et al.  Pulmonary vascular permeability during the adult respiratory distress syndrome: a positron emission tomographic study. , 1988, The American review of respiratory disease.

[3]  S. Matsui,et al.  Annealing effects for implanted Y‐Ba‐Cu‐O superconductors , 1988 .

[4]  Acnp Snm Task Force on Clinical Pet Positron Emission Tomography: Clinical Status in the United States in 1987 , 1988 .

[5]  W. R. Kennedy,et al.  Cyclotrons and Radiopharmaceuticals in Positron Emission Tomography , 1988 .

[6]  D. Schuster,et al.  Quantifying the effects of mixed venous PO2 on regional pulmonary perfusion with positron emission tomography during lobar hypoxic ventilation in dogs , 1988 .

[7]  T Jones,et al.  Glucose utilization in vivo by human pulmonary neoplasms , 1987, Cancer.

[8]  H. M. Thomas,et al.  Lipoxygenase and cyclooxygenase blockade by BW 755C enhances pulmonary hypoxic vasoconstriction. , 1987, Journal of applied physiology.

[9]  K. B. Larson,et al.  Strategies for in vivo Measurement of Receptor Binding Using Positron Emission Tomography , 1986, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[10]  M. Mintun,et al.  Regional lung water and hematocrit determined by positron emission tomography. , 1985, Journal of applied physiology.

[11]  J. Mazziotta,et al.  Positron emission tomography: human brain function and biochemistry. , 1985, Science.

[12]  M. Heymann,et al.  Leukotriene Inhibition Prevents and Reverses Hypoxic Pulmonary Vasoconstriction in Newborn Lambs , 1985, Pediatric Research.

[13]  M E Raichle,et al.  Positron emission tomography and its application to the study of cerebrovascular disease in man. , 1985, Stroke.

[14]  H. Sugerman,et al.  Gamma scintigraphic analysis of albumin flux in patients with acute respiratory distress syndrome. , 1984, Surgery.

[15]  N. Voelkel,et al.  Leukotriene synthesis and receptor blockers block hypoxic pulmonary vasoconstriction. , 1984, Journal of applied physiology: respiratory, environmental and exercise physiology.

[16]  B. Sobel,et al.  Cardiac positron tomography. , 1983, Chest.

[17]  J. Baron,et al.  11C-Labeled ketanserin: A selective serotonin S2 antagonist , 1983 .

[18]  J. Benumof,et al.  PAO2 and PVO2 interaction on hypoxic pulmonary vasoconstriction. , 1982, Journal of applied physiology: respiratory, environmental and exercise physiology.

[19]  M. Ter-pogossian Special characteristics and potential for dynamic function studies with PET. , 1982, Seminars in nuclear medicine.

[20]  J C Mazziotta,et al.  Quantitation in Positron Emission Computed Tomography: 5. Physical–Anatomical Effects , 1981, Journal of computer assisted tomography.

[21]  G. Beller,et al.  Scintigraphic detection of pulmonary emboli by serial positron imaging of inhaled 15O-labeled carbon dioxide. , 1978, The New England journal of medicine.

[22]  M J Welch,et al.  Measurement of regional substrate utilization rates by emission tomography. , 1978, Science.

[23]  J. West,et al.  Ventilation-perfusion inequality in chronic obstructive pulmonary disease. , 1977, The Journal of clinical investigation.

[24]  P. Buckingham,et al.  Distribution of extravascular fluid volumes in isolated perfused lungs measured with H215O. , 1976, The Journal of clinical investigation.

[25]  Preparation of short half-lived radioactive gases for medical studies. , 1968, Radiation research.

[26]  W. Milnor,et al.  The Pulmonary Blood Volume in Rheumatic Heart Disease and Its Alteration by Isoproterenol , 1963, Circulation.